PIEZO1 mutations impact on early clinical manifestations of myelodysplastic syndromes
Am J Hematol
.
2023 Apr;98(4):E72-E75.
doi: 10.1002/ajh.26863.
Epub 2023 Feb 14.
Authors
Enrico Attardi
1
,
Immacolata Andolfo
2
3
,
Roberta Russo
2
3
,
Lucia Tiberi
4
5
,
Marco Gabriele Raddi
1
,
Barbara Eleni Rosato
2
3
,
Roberta Marra
2
3
,
Daniela Formicola
5
,
Federica Del Giudice
3
,
Alice Brogi
1
,
Angela Consagra
1
,
Cristina Amato
1
,
Alessandro Sanna
1
,
Rosangela Artuso
5
,
Achille Iolascon
2
3
,
Valeria Santini
1
Affiliations
1
MDS Unit, Hematology, AOU Careggi - Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
2
Department of Molecular Medicine and Medical Biotechnologies, "Federico II" University of Naples, Naples, Italy.
3
CEINGE, Biotecnologie Avanzate, Naples, Italy.
4
Department of Biomedical Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy.
5
Medical Genetics Unit, Meyer University Hospital, Florence, Italy.
PMID:
36695705
DOI:
10.1002/ajh.26863
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Ion Channels / genetics
Mutation
Myelodysplastic Syndromes* / genetics
Substances
PIEZO1 protein, human
Ion Channels